Dr. Wu Skincare Co., Ltd. carries a market capitalization of 4.10B, placing it among publicly traded companies globally. Its enterprise value stands at 4.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.10B |
| Enterprise Value | 4.55B |
Dr. Wu Skincare Co., Ltd. currently has 45.05M shares outstanding.
| Shares Outstanding | 45.05M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Dr. Wu Skincare Co., Ltd. trades at a trailing price-to-earnings ratio of 15.27. The price-to-sales ratio is 4.58, and the price-to-book ratio stands at 6.42.
| PE Ratio | 15.27 |
| PS Ratio | 4.58 |
| PB Ratio | 6.42 |
| P/TBV Ratio | 3.95 |
| P/FCF Ratio | 15.42 |
| P/OCF Ratio | 15.68 |
On an enterprise value basis, Dr. Wu Skincare Co., Ltd. trades at an EV/EBITDA multiple of 10.66 and an EV/FCF ratio of 13.08. The EV/Sales ratio of 3.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.90 |
| EV / EBITDA | 10.66 |
| EV / EBIT | 10.66 |
| EV / FCF | 13.08 |
Dr. Wu Skincare Co., Ltd. maintains a current ratio of 5.71, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.02, indicating elevated leverage, while an interest coverage ratio of 307.26 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.71 |
| Quick Ratio | 4.09 |
| Debt / Equity | 3.02 |
| Debt / EBITDA | 0.10 |
| Interest Coverage | 307.26 |
Dr. Wu Skincare Co., Ltd. posts a return on equity of 40.83 and a return on invested capital of 22.71.
| Return on Equity (ROE) | 40.83 |
| Return on Assets (ROA) | 20.97 |
| Return on Invested Capital (ROIC) | 22.71 |
| Return on Capital Employed (ROCE) | 38.96 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.20 |
Over the trailing twelve months, Dr. Wu Skincare Co., Ltd. has paid 91.21M in income taxes, reflecting an effective tax rate of 20.66.
| Income Tax | 91.21M |
| Effective Tax Rate | 20.66 |
Dr. Wu Skincare Co., Ltd.'s stock has declined approximately -30.45802% over the past 52 weeks. The 50-day moving average sits at 98.29, while the 200-day moving average is 113.53.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.45802% |
| 50-Day Moving Average | 98.29 |
| 200-Day Moving Average | 113.53 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Dr. Wu Skincare Co., Ltd. generated 1.17B in revenue and converted that into 350.27M in net income, yielding earnings per share of 7.76. EBITDA reached 427.10M, while operating income came in at 427.10M.
| Revenue | 1.17B |
| Gross Profit | 805.59M |
| Operating Income | 427.10M |
| Pretax Income | 441.49M |
| Net Income | 350.27M |
| EBITDA | 427.10M |
| EBIT | 427.10M |
| Earnings Per Share (EPS) | 7.76 |
Dr. Wu Skincare Co., Ltd. holds 836.03M in cash and equivalents against 40.98M in total debt, resulting in a net debt position of -326.33M. Total book value stands at 832.68M, with working capital of 962.56M providing operational flexibility.
| Cash & Cash Equivalents | 836.03M |
| Total Debt | 40.98M |
| Net Debt | -326.33M |
| Equity (Book Value) | 832.68M |
| Book Value Per Share | 18.45 |
| Working Capital | 962.56M |
Dr. Wu Skincare Co., Ltd. produced 340.92M in operating cash flow over the past twelve months. After subtracting -5.91M in capital expenditures, free cash flow totaled 335.01M - equivalent to 7.42 per share.
| Operating Cash Flow | 340.92M |
| Capital Expenditures | -5.91M |
| Free Cash Flow | 335.01M |
| FCF Per Share | 7.42 |
Dr. Wu Skincare Co., Ltd. operates with a gross margin of 68.96, reflecting its pricing power and cost economics. The operating margin of 36.56 and net profit margin of 29.98 provide insight into operational efficiency.
| Gross Margin | 68.96 |
| Operating Margin | 36.56 |
| Pretax Margin | 37.79 |
| Profit Margin | 29.98 |
| EBITDA Margin | 36.56 |
The company's payout ratio of 102.89 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 7.99 |
| Dividend Yield | N/A |
| Payout Ratio | 102.89 |
| Shareholder Yield | 8.61 |
| FCF Yield | 6.49 |
Dr. Wu Skincare Co., Ltd.'s most recent stock split took place on May 26, 2016 with a 2:3 split ratio.
| Last Split Date | 5/26/2016 |
| Split Ratio | 2:3 |
Dr. Wu Skincare Co., Ltd. posts an Altman Z-Score of 16.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.29 |